Research map: Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The ‘Good’, the ‘Bad’, and the ‘Ugly’ After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer

Back to the article

Papers in this map

  1. Screening and Prostate-Cancer Mortality in a Randomized European Study · Fritz H. Schröder · 2009 · 4037 citations · Cited by this paper
  2. Autologous transobturator sling: From mesh to human tissue. A case report · 2026 · Related
  3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up · Fritz H. Schröder · 2014 · 1591 citations · Cited by this paper
  4. Irreversible bladder damage after intravesical BCG therapy requiring radical cystectomy: A case report · 2026 · Related
  5. The Lancet Commission on prostate cancer: planning for the surge in cases · Nicholas David James · 2024 · 726 citations · Cited by this paper
  6. Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy · 2026 · Related
  7. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer · Jonas Hugosson · 2019 · 717 citations · Cited by this paper
  8. Urethral necrosis after catheterization in a patient with an artificial urinary sphincter: Why physical examination and appropriate drainage matter · 2026 · Related
  9. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program · Leire Palencia-Madrid · 2010 · 437 citations · Cited by this paper
  10. Propensity score–matched comparison of radical prostatectomy with versus without pelvic lymph node dissection in high-risk prostate cancer patients · 2026 · Related
  11. ADJUSTING FOR NON-COMPLIANCE AND CONTAMINATION IN RANDOMIZED CLINICAL TRIALS · Jack M. Cuzick · 1997 · 310 citations · Cited by this paper
  12. Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study · 2026 · Related
  13. Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) · Monique J. Roobol · 2009 · 218 citations · Cited by this paper
  14. DEEP-URO RA/LP: DE-Escalation of antibiotic Prophylaxis in UROlogical procedures in Robot-Assisted or Laparoscopic Prostatectomy · 2026 · Related
  15. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial · Tobias Nordström · 2021 · 210 citations · Cited by this paper
  16. Fluid dynamics in penile Doppler ultrasound: Cavernosal Kinetic Energy Index (CKEI) vs. Resistive Index (RI) for erection hardness · 2026 · Related
  17. Psychosocial Determinants of Socioeconomic Inequalities in Cancer Screening Participation: A Conceptual Framework · Christian von Wagner · 2011 · 176 citations · Cited by this paper
  18. Prognostic value of seven urinary tissue proteomic biomarkers in prostate cancer · 2026 · Related
  19. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: A review · Teresa Spadea · 2010 · 151 citations · Cited by this paper
  20. Multiparametric Magnetic Resonance Imaging Without Artificial Erection for Preoperative Staging of Primary Penile Carcinoma · 2026 · Related
  21. Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality · Jonas Hugosson · 2017 · 112 citations · Cited by this paper
  22. Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI · Anssi P. Auvinen · 2024 · 106 citations · Cited by this paper
  23. Prostate-specific Antigen–Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer · Leonard P. Bokhorst · 2013 · 97 citations · Cited by this paper
  24. European Study of Prostate Cancer Screening — 23-Year Follow-up · Monique J. Roobol · 2025 · 95 citations · Cited by this paper
  25. A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial · Christian Arsov · 2022 · 94 citations · Cited by this paper
  26. Determining the cause of death in randomized screening trial(s) for prostate cancer · Harry J. de Koning · 2003 · 93 citations · Cited by this paper
  27. Why do men refuse or attend population-based screening for prostate cancer? · Hans C. M. den Nijs · 2000 · 91 citations · Cited by this paper
  28. Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening · Stefano Ciatto · 2003 · 74 citations · Cited by this paper
  29. Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men · Ola Bratt · 2023 · 68 citations · Cited by this paper
  30. Factors promoting breast, cervical and colorectal cancer screenings participation: A systematic review · Federica Vallone · 2022 · 66 citations · Cited by this paper
  31. Assessment of causes of death in a prostate cancer screening trial · Tuukka Mäkinen · 2007 · 64 citations · Cited by this paper
  32. The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate · Kimia Kohestani · 2021 · 60 citations · Cited by this paper
  33. Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer · Tuomas P. Kilpeläinen · 2016 · 56 citations · Cited by this paper
  34. Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U · Hendrik Van Poppel · 2023 · 54 citations · Cited by this paper
  35. Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review · Saloa Unanue-Arza · 2020 · 46 citations · Cited by this paper
  36. Does an organised screening programme reduce the inequalities in breast cancer survival? · Donella Puliti · 2011 · 39 citations · Cited by this paper
  37. Prostate Cancer Early Detection in the European Union and UK · Renée C. A. Leenen · 2024 · 37 citations · Cited by this paper
  38. Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam) · Melissa Kerkhof · 2010 · 35 citations · Cited by this paper
  39. Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer · Tuomas P. Kilpeläinen · 2017 · 33 citations · Cited by this paper

Source: OpenAlex (CC0)